First Page | Meta Content | |
---|---|---|
Document Date: 2013-08-13 12:10:35Open Document File Size: 107,71 KBShare Result on FacebookCompanyClinical Commissioning Group / The CUH Clinical Biochemistry Laboratory / NHS England NHS England / Cambridge University Hospitals NHS Foundation Trust / /CountryNorthern Ireland / United Kingdom / Scotland / Wales / /CurrencyGBP / /EventProduct Issues / FDA Phase / /FacilityThe clinic / Weekly clinic / /IndustryTermtreatment algorithms / radiology services / diabetes care / diabetes services / specialised imaging / /MedicalConditionRabson Mendenhall syndrome / Outcome Variables Outcome Diabetes / extreme insulin resistance / Insulin-resistant diabetes / severe lipodystrophy / Clinical Hyperandrogenism / severe insulin resistance / recurrent pancreatitis / dysfunction / lipodystrophies / severe insulin resistance/lipodystrophy / unexplained severe insulin resistance / largely chronic metabolic disorders / lupus / proteinuria / Donohue syndrome / insulin resistance / lipodystrophy / disease / metabolically devastating disorders / local diabetes / lipodystrophy/severe insulin resistance / diabetes / i.e. diabetes / acanthosis nigricans / autoimmune disease / pancreatitis / locally commissioned diabetes / syndromic severe insulin resistance / severe insulin resistance/ / breach Due Diabetes / fibrosis / disorders / severe dyslipidaemia/ pancreatitis / poorly controlled diabetes / /MedicalTreatmentimmunosuppressive therapies / emergency treatment / Immunosuppression / immunosuppressive therapy / /OrganizationCambridge University / Specialist Assay Service / National Insulin Resistant Diabetes Service / NHS Commissioning Board / English GP / European Union / NHS / National Severe Insulin Resistance Service / /PositionGeneral Practitioner / targeted specialist / paediatric specialist / consultant / dietician / genetic counsellor / A- SERVICE SPECIFICATION Service Specification No. Service Commissioner / responsible commissioner / commissioner / specialist nurse / specialist dietician / /ProductGlucagon / GPL1 / insulin receptor function / /Technologyantibodies / GPS / MRI / treatment algorithms / /SocialTag |